lipoxin-b4 and Hemorrhagic-Disorders

lipoxin-b4 has been researched along with Hemorrhagic-Disorders* in 1 studies

Other Studies

1 other study(ies) available for lipoxin-b4 and Hemorrhagic-Disorders

ArticleYear
A cluster of immunoresolvents links coagulation to innate host defense in human blood.
    Science signaling, 2017, Aug-01, Volume: 10, Issue:490

    Blood coagulation is a protective response that prevents excessive bleeding upon blood vessel injury. We investigated the relationship between coagulation and the resolution of inflammation and infection by lipid mediators (LMs) through metabololipidomics-based profiling of human whole blood (WB) during coagulation. We identified temporal clusters of endogenously produced prothrombotic and proinflammatory LMs (eicosanoids), as well as specialized proresolving mediators (SPMs). In addition to eicosanoids, a specific SPM cluster was identified that consisted of resolvin E1 (RvE1), RvD1, RvD5, lipoxin B

    Topics: Animals; Blood Coagulation; Cells, Cultured; Docosahexaenoic Acids; Escherichia coli; Hemorrhagic Disorders; Humans; Immunity, Innate; Leukocytes; Lipoxins; Macrophages; Male; Mice; Neutrophils; Peritonitis; Phagocytosis

2017